Last reviewed · How we verify
Sonazoid and Sonovue
Sonazoid and Sonovue are ultrasound contrast agents that work by enhancing the contrast of ultrasound images through the use of microbubbles.
Sonazoid and Sonovue are ultrasound contrast agents that work by enhancing the contrast of ultrasound images through the use of microbubbles. Used for Liver imaging, Kidney imaging.
At a glance
| Generic name | Sonazoid and Sonovue |
|---|---|
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Drug class | Ultrasound contrast agent |
| Modality | Small molecule |
| Therapeutic area | Imaging |
| Phase | Phase 3 |
Mechanism of action
They contain perflutren lipid microspheres that reflect sound waves, allowing for improved visualization of blood flow and tissue structure during ultrasound imaging. This can be particularly useful in procedures such as liver and kidney imaging.
Approved indications
- Liver imaging
- Kidney imaging
Common side effects
- Allergic reactions
- Hypersensitivity reactions
Key clinical trials
- Y-90 Treatment Response Using Transarterial Radioembolization (PHASE2)
- Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
- SHAPE of Portal Hypertension in Children (PHASE2)
- Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC (PHASE3)
- An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging (PHASE3)
- Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |